» Articles » PMID: 27667094

Smoothing a Rugged Protein Folding Landscape by Sequence-based Redesign

Abstract

The rugged folding landscapes of functional proteins puts them at risk of misfolding and aggregation. Serine protease inhibitors, or serpins, are paradigms for this delicate balance between function and misfolding. Serpins exist in a metastable state that undergoes a major conformational change in order to inhibit proteases. However, conformational labiality of the native serpin fold renders them susceptible to misfolding, which underlies misfolding diseases such as α-antitrypsin deficiency. To investigate how serpins balance function and folding, we used consensus design to create conserpin, a synthetic serpin that folds reversibly, is functional, thermostable, and polymerization resistant. Characterization of its structure, folding and dynamics suggest that consensus design has remodeled the folding landscape to reconcile competing requirements for stability and function. This approach may offer general benefits for engineering functional proteins that have risky folding landscapes, including the removal of aggregation-prone intermediates, and modifying scaffolds for use as protein therapeutics.

Citing Articles

Comparison of structures and inhibition activities of serine protease inhibitors of Trichinella spiralis and Trichinella pseudospiralis.

Li R, Zhang B, Chen C Cell Biosci. 2025; 15(1):35.

PMID: 40082967 PMC: 11905679. DOI: 10.1186/s13578-025-01375-0.


Protein stability is determined by single-site bias rather than pairwise covariance.

Sternke M, Tripp K, Barrick D bioRxiv. 2025; .

PMID: 39868188 PMC: 11760396. DOI: 10.1101/2025.01.09.632118.


The stability and dynamics of computationally designed proteins.

Gonzalez N, Li B, McCully M Protein Eng Des Sel. 2022; 35.

PMID: 35174855 PMC: 9214642. DOI: 10.1093/protein/gzac001.


Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery.

Sanrattana W, Smits S, Barendrecht A, van Kleef N, El Otmani H, Zivkovic M J Thromb Haemost. 2021; 20(2):353-365.

PMID: 34653316 PMC: 9298318. DOI: 10.1111/jth.15554.


Therapeutic SERPINs: Improving on Nature.

Maas C, de Maat S Front Cardiovasc Med. 2021; 8:648349.

PMID: 33869308 PMC: 8044344. DOI: 10.3389/fcvm.2021.648349.


References
1.
Yamasaki M, Sendall T, Pearce M, Whisstock J, Huntington J . Molecular basis of α1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer. EMBO Rep. 2011; 12(10):1011-7. PMC: 3185345. DOI: 10.1038/embor.2011.171. View

2.
Karpusas M, Baase W, Matsumura M, Matthews B . Hydrophobic packing in T4 lysozyme probed by cavity-filling mutants. Proc Natl Acad Sci U S A. 1989; 86(21):8237-41. PMC: 298255. DOI: 10.1073/pnas.86.21.8237. View

3.
Lawrence M, Phillips K, Liu D . Supercharging proteins can impart unusual resilience. J Am Chem Soc. 2007; 129(33):10110-2. PMC: 2820565. DOI: 10.1021/ja071641y. View

4.
James E, Bottomley S . The mechanism of alpha 1-antitrypsin polymerization probed by fluorescence spectroscopy. Arch Biochem Biophys. 1998; 356(2):296-300. DOI: 10.1006/abbi.1998.0751. View

5.
Horovitz A, Serrano L, Avron B, Bycroft M, Fersht A . Strength and co-operativity of contributions of surface salt bridges to protein stability. J Mol Biol. 1990; 216(4):1031-44. DOI: 10.1016/S0022-2836(99)80018-7. View